サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1721212

脳卒中治療の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2035年）

Stroke Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 165 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
脳卒中治療の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2035年）
出版日: 2025年03月26日
発行: Transparency Market Research
ページ情報: 英文 165 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳卒中治療市場：調査範囲

TMRの調査レポート「脳卒中治療の世界市場」は、2025年～2035年の予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年～2035年の世界の脳卒中治療市場の収益と予測を提供します。また、2025年～2035年の世界の脳卒中治療市場のCAGR%も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、脳卒中治療市場を推察しました。

市場スナップショット
2024年の市場規模 39億米ドル
2035年の市場規模 94億米ドル
CAGR 8.4%

当レポートでは、世界の脳卒中治療市場の競合情勢について調査しています。世界の脳卒中治療市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の脳卒中治療市場における企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の脳卒中治療市場の分析と予測（2020年～2035年）

第5章 主要洞察

  • 主要な業界イベント
  • PESTEL分析
  • 主要国・地域別の規制シナリオ
  • ポーターのファイブフォース分析
  • 製品/ブランド分析
  • サプライチェーン分析
  • パイプライン分析

第6章 世界の市場分析および予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：タイプ別（2020年～2035年）
    • 虚血性脳卒中
      • 血栓性脳卒中
      • 塞栓性脳卒中
    • 出血性脳卒中
      • 脳内出血
      • くも膜下出血
  • 市場の魅力分析：タイプ別

第7章 世界の市場分析および予測：薬剤クラス別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：薬剤クラス別（2020年～2035年）
    • 抗凝固薬
    • 抗血小板薬
    • 組織プラスミノーゲン活性化因子（tPA）
    • スタチン
    • ベータ遮断薬
    • その他
  • 市場の魅力分析：薬剤クラス別

第8章 世界の市場分析および予測：投与経路別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：投与経路別（2020年～2035年）
    • 経口
    • 非経口
  • 市場の魅力分析：投与経路別

第9章 世界の市場分析および予測：薬剤入手可能性別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：薬剤入手可能性別（2020年～2035年）
    • ブランド
    • ジェネリック
  • 市場の魅力分析：薬剤入手可能性別

第10章 世界の市場分析および予測：販売チャネル別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：流通チャネル別（2020年～2035年）
    • 院内薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力分析：流通チャネル別

第11章 世界の市場分析および予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別（2020年～2035年）
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第12章 北米の市場分析と予測

第13章 欧州の市場分析と予測

第14章 アジア太平洋の市場分析と予測

第15章 ラテンアメリカの市場分析と予測

第16章 中東・アフリカの市場分析と予測

第17章 競合情勢

  • 市場企業：競合マトリックス（企業階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • Bristol-Myers Squibb Company
    • Sanofi
    • F. Hoffmann-La Roche（Genentech）
    • Daiichi Sankyo Company, Limited
    • AstraZeneca
    • Biogen Inc.
    • Johnson & Johnson Services, Inc.
    • Bayer AG
    • Eli Lilly and Company
    • Mylan
    • Teva Pharmaceuticals
    • Zydus Cadila
    • Sun Pharmaceutical
図表

List of Tables

  • Table 01: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 02: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 03: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 04: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 05: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 06: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 07: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 08: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 09: North America - Stroke Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 10: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 11: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 12: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 13: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 14: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 15: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 16: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 19: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 20: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 21: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 22: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 23: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 24: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 25: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 27: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 28: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 29: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 30: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 31: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 32: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 33: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 34: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 35: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 36: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 37: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 38: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 39: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 40: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 41: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 42: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 43: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 44: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 45: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 46: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 47: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 48: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 03: Global Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 04: Global Stroke Treatment Market Revenue (US$ Bn), by Ischemic Stroke, 2020-2035
  • Figure 05: Global Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 06: Global Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 07: Global Stroke Treatment Market Revenue (US$ Bn), by Anticoagulants, 2020-2035
  • Figure 08: Global Stroke Treatment Market Revenue (US$ Bn), by Antiplatelets, 2020-2035
  • Figure 09: Global Stroke Treatment Market Revenue (US$ Bn), by Tissue plasminogen activator (tPA), 2020-2035
  • Figure 10: Global Stroke Treatment Market Revenue (US$ Bn), by Statins, 2020-2035
  • Figure 11: Global Stroke Treatment Market Revenue (US$ Bn), by Beta-Blockers, 2020-2035
  • Figure 12: Global Stroke Treatment Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 13: Global Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 14: Global Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 15: Global Stroke Treatment Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 16: Global Stroke Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035
  • Figure 17: Global Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 18: Global Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 19: Global Stroke Treatment Market Revenue (US$ Bn), by Branded, 2020-2035
  • Figure 20: Global Stroke Treatment Market Revenue (US$ Bn), by Generic, 2020-2035
  • Figure 21: Global Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 22: Global Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 23: Global Stroke Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 24: Global Stroke Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 25: Global Stroke Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035
  • Figure 26: Global Stroke Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 27: Global Stroke Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 28: North America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 29: North America - Stroke Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: North America - Stroke Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 31: North America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 32: North America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 33: North America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 34: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 35: North America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 36: North America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 37: North America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 38: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 39: North America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 40: North America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 41: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 42: Europe - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 43: Europe - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 44: Europe - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 45: Europe - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 46: Europe - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 47: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 48: Europe - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 49: Europe - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 50: Europe - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 51: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 52: Europe - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 53: Europe - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 54: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 55: Asia Pacific - Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 56: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 57: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 58: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 59: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 60: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 61: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 62: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 63: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 64: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 65: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 67: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 68: Latin America - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 69: Latin America - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 70: Latin America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 71: Latin America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 72: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 73: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 74: Latin America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 75: Latin America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 76: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 77: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 78: Latin America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 79: Latin America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 80: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 81: Middle East & Africa - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 82: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 83: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 84: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 85: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 86: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 87: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 88: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 89: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 90: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 91: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 92: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
目次
Product Code: TMRGL73917

Stroke Treatment Market - Scope of Report

TMR's report on the global stroke treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global stroke treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stroke treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the stroke treatment market.

Market Snapshot
Market Value in 2024US$ 3.9 Bn
Market Value in 2035US$ 9.4 Bn
CAGR8.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stroke treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stroke treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stroke treatment market.

The report delves into the competitive landscape of the global stroke treatment market. Key players operating in the global stroke treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stroke treatment market profiled in this report.

Key Questions Answered in Global stroke treatment Market Report:

  • What is the sales/revenue generated by stroke treatment across all regions during the forecast period?
  • What are the opportunities in the global stroke treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Stroke Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global stroke treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global stroke treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stroke treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stroke Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Stroke Treatment Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. PESTEL Analysis
  • 5.3. Regulatory Scenario by Key Countries/Regions
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. Product/Brand Analysis
  • 5.6. Supply Chain Analysis
  • 5.7. Pipeline Analysis

6. Global Stroke Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020-2035
    • 6.3.1. Ischemic Stroke
      • 6.3.1.1. Thrombotic Stroke
      • 6.3.1.2. Embolic Stroke
    • 6.3.2. Hemorrhagic Stroke
      • 6.3.2.1. Intracerebral Hemorrhage
      • 6.3.2.2. Subarachnoid Hemorrhage
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Stroke Treatment Market Analysis and Forecast, by Drug Class

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug Class, 2020-2035
    • 7.3.1. Anticoagulants
    • 7.3.2. Antiplatelets
    • 7.3.3. Tissue plasminogen activator (tPA)
    • 7.3.4. Statins
    • 7.3.5. Beta-Blockers
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Drug Class

8. Global Stroke Treatment Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2020-2035
    • 8.3.1. Oral
    • 8.3.2. Parenteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Stroke Treatment Market Analysis and Forecast, by Drug Availability

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Drug Availability, 2020-2035
    • 9.3.1. Branded
    • 9.3.2. Generic
  • 9.4. Market Attractiveness Analysis, by Drug Availability

10. Global Stroke Treatment Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2020-2035
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Stroke Treatment Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2020-2035
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Stroke Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020-2035
    • 12.2.1. Ischemic Stroke
      • 12.2.1.1. Thrombotic Stroke
      • 12.2.1.2. Embolic Stroke
    • 12.2.2. Hemorrhagic Stroke
      • 12.2.2.1. Intracerebral Hemorrhage
      • 12.2.2.2. Subarachnoid Hemorrhage
  • 12.3. Market Value Forecast, by Drug Class, 2020-2035
    • 12.3.1. Anticoagulants
    • 12.3.2. Antiplatelets
    • 12.3.3. Tissue plasminogen activator (tPA)
    • 12.3.4. Statins
    • 12.3.5. Beta-Blockers
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 12.4.1. Oral
    • 12.4.2. Parenteral
  • 12.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 12.5.1. Branded
    • 12.5.2. Generic
  • 12.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 12.6.1. Hospital Pharmacies
    • 12.6.2. Retail Pharmacies
    • 12.6.3. Online Pharmacies
  • 12.7. Market Value Forecast, by Country, 2020-2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type
    • 12.8.2. By Drug Class
    • 12.8.3. By Route of Administration
    • 12.8.4. By Drug Availability
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Stroke Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020-2035
    • 13.2.1. Ischemic Stroke
      • 13.2.1.1. Thrombotic Stroke
      • 13.2.1.2. Embolic Stroke
    • 13.2.2. Hemorrhagic Stroke
      • 13.2.2.1. Intracerebral Hemorrhage
      • 13.2.2.2. Subarachnoid Hemorrhage
  • 13.3. Market Value Forecast, by Drug Class, 2020-2035
    • 13.3.1. Anticoagulants
    • 13.3.2. Antiplatelets
    • 13.3.3. Tissue plasminogen activator (tPA)
    • 13.3.4. Statins
    • 13.3.5. Beta-Blockers
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 13.4.1. Oral
    • 13.4.2. Parenteral
  • 13.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 13.5.1. Branded
    • 13.5.2. Generic
  • 13.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 13.6.1. Hospital Pharmacies
    • 13.6.2. Retail Pharmacies
    • 13.6.3. Online Pharmacies
  • 13.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.7.1. Germany
    • 13.7.2. UK
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type
    • 13.8.2. By Drug Class
    • 13.8.3. By Route of Administration
    • 13.8.4. By Drug Availability
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Stroke Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020-2035
    • 14.2.1. Ischemic Stroke
      • 14.2.1.1. Thrombotic Stroke
      • 14.2.1.2. Embolic Stroke
    • 14.2.2. Hemorrhagic Stroke
      • 14.2.2.1. Intracerebral Hemorrhage
      • 14.2.2.2. Subarachnoid Hemorrhage
  • 14.3. Market Value Forecast, by Drug Class, 2020-2035
    • 14.3.1. Anticoagulants
    • 14.3.2. Antiplatelets
    • 14.3.3. Tissue plasminogen activator (tPA)
    • 14.3.4. Statins
    • 14.3.5. Beta-Blockers
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 14.4.1. Oral
    • 14.4.2. Parenteral
  • 14.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 14.5.1. Branded
    • 14.5.2. Generic
  • 14.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 14.6.1. Hospital Pharmacies
    • 14.6.2. Retail Pharmacies
    • 14.6.3. Online Pharmacies
  • 14.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type
    • 14.8.2. By Drug Class
    • 14.8.3. By Route of Administration
    • 14.8.4. By Drug Availability
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Stroke Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2020-2035
    • 15.2.1. Ischemic Stroke
      • 15.2.1.1. Thrombotic Stroke
      • 15.2.1.2. Embolic Stroke
    • 15.2.2. Hemorrhagic Stroke
      • 15.2.2.1. Intracerebral Hemorrhage
      • 15.2.2.2. Subarachnoid Hemorrhage
  • 15.3. Market Value Forecast, by Drug Class, 2020-2035
    • 15.3.1. Anticoagulants
    • 15.3.2. Antiplatelets
    • 15.3.3. Tissue plasminogen activator (tPA)
    • 15.3.4. Statins
    • 15.3.5. Beta-Blockers
    • 15.3.6. Others
  • 15.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 15.4.1. Oral
    • 15.4.2. Parenteral
  • 15.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 15.5.1. Branded
    • 15.5.2. Generic
  • 15.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 15.6.1. Hospital Pharmacies
    • 15.6.2. Retail Pharmacies
    • 15.6.3. Online Pharmacies
  • 15.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type
    • 15.8.2. By Drug Class
    • 15.8.3. By Route of Administration
    • 15.8.4. By Drug Availability
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Stroke Treatment Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type, 2020-2035
    • 16.2.1. Ischemic Stroke
      • 16.2.1.1. Thrombotic Stroke
      • 16.2.1.2. Embolic Stroke
    • 16.2.2. Hemorrhagic Stroke
      • 16.2.2.1. Intracerebral Hemorrhage
      • 16.2.2.2. Subarachnoid Hemorrhage
  • 16.3. Market Value Forecast, by Drug Class, 2020-2035
    • 16.3.1. Anticoagulants
    • 16.3.2. Antiplatelets
    • 16.3.3. Tissue plasminogen activator (tPA)
    • 16.3.4. Statins
    • 16.3.5. Beta-Blockers
    • 16.3.6. Others
  • 16.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 16.4.1. Oral
    • 16.4.2. Parenteral
  • 16.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 16.5.1. Branded
    • 16.5.2. Generic
  • 16.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 16.6.1. Hospital Pharmacies
    • 16.6.2. Retail Pharmacies
    • 16.6.3. Online Pharmacies
  • 16.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type
    • 16.8.2. By Drug Class
    • 16.8.3. By Route of Administration
    • 16.8.4. By Drug Availability
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. Bristol-Myers Squibb Company
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Sanofi
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. F. Hoffmann-La Roche (Genentech)
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Daiichi Sankyo Company, Limited
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. AstraZeneca
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Biogen Inc.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Johnson & Johnson Services, Inc.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Bayer AG
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Eli Lilly and Company
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Mylan
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Teva Pharmaceuticals
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. Zydus Cadila
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. Sun Pharmaceutical
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments